PubRank
Search
About
Hee-Seung Bom
Author PubWeight™ 38.47
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer.
Eur J Nucl Med Mol Imaging
2012
2.04
2
Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
Eur J Cancer
2011
1.23
3
Incidental focal F-18 FDG accumulation in lung parenchyma without abnormal CT findings.
Ann Nucl Med
2009
1.19
4
Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli.
Mol Imaging Biol
2007
1.16
5
Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy.
Mol Ther
2010
1.12
6
Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin.
AJR Am J Roentgenol
2010
1.11
7
Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections.
Haematologica
2004
1.05
8
Iodine-131 uptake in focal bronchiectasis mimicking metastatic thyroid cancer.
Clin Nucl Med
2003
1.04
9
In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium.
Ann Nucl Med
2006
1.03
10
Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent.
Mol Ther
2013
0.99
11
Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies.
J Control Release
2005
0.95
12
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era.
Ann Hematol
2012
0.95
13
Evaluation of a mitochondrial voltage sensor, (18F-fluoropentyl)triphenylphosphonium cation, in a rat myocardial infarction model.
J Nucl Med
2012
0.94
14
Expression of e-cadherin and catenins in early gastric cancer.
J Clin Gastroenterol
2002
0.91
15
A stepwise approach using metabolic volume and SUVmax to differentiate malignancy and dysplasia from benign colonic uptakes on 18F-FDG PET/CT.
Clin Nucl Med
2012
0.88
16
Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography.
Ann Nucl Med
2012
0.87
17
Polyethylene glycol (PEG) modified 99mTc-HMPAO-liposome for improving blood circulation and biodistribution: the effect of the extent of PEGylation.
Cancer Biother Radiopharm
2005
0.86
18
Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET/CT.
Clin Nucl Med
2012
0.85
19
Intratumoral injection of 188Re labeled cationic polyethylenimine conjugates: a preliminary report.
J Korean Med Sci
2004
0.85
20
Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.
Eur J Nucl Med Mol Imaging
2011
0.84
21
Engineering and visualization of bacteria for targeting infarcted myocardium.
Mol Ther
2011
0.84
22
Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution.
J Nucl Med
2005
0.83
23
Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment.
Biomaterials
2003
0.83
24
Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer.
Lung Cancer
2013
0.82
25
Monitoring the effect of PEGylation on polyethylenimine in vivo using nuclear imaging technique.
Nucl Med Biol
2004
0.81
26
Surgically resected isolated hepatic metastasis from non-small cell lung cancer: a case report.
J Thorac Oncol
2006
0.80
27
Early metabolic response on 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography after concurrent chemoradiotherapy for advanced stage III non-small cell lung cancer is correlated with local tumor control and survival.
Anticancer Res
2014
0.79
28
Radioprotective effect of chitosan in sub-lethally X-ray irradiated mice.
J Radiat Res
2003
0.79
29
Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m--labeled metronidazole.
Stroke
2003
0.79
30
Glucosylated polyethylenimine as a tumor-targeting gene carrier.
Arch Pharm Res
2005
0.79
31
Clinical Usefulness of (18)F-FDG PET/CT in the Detection of Early Recurrence in Treated Cervical Cancer Patients with Unexplained Elevation of Serum Tumor Markers.
Chonnam Med J
2013
0.78
32
Ionic strength-sensitive pullulan acetate nanoparticles (PAN) for intratumoral administration of radioisotope: ionic strength-dependent aggregation behavior and (99m)Technetium retention property.
Colloids Surf B Biointerfaces
2007
0.78
33
Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis.
Ann Hematol
2013
0.78
34
In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter.
Nucl Med Biol
2002
0.78
35
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma.
Ann Hematol
2008
0.78
36
Changes in (18)f-fluorodeoxyglucose uptake in the spinal cord in a healthy population on serial positron emission tomography/computed tomography.
Chonnam Med J
2013
0.77
37
Retention of iodine-131 in a thoracic esophageal diverticulum mimicking metastatic thyroid cancer.
Clin Nucl Med
2002
0.76
38
Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
Hell J Nucl Med
2014
0.76
39
Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.
Clin Nucl Med
2003
0.76
40
Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan.
Nucl Med Biol
2006
0.76
41
A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment.
Case Rep Oncol
2011
0.75
42
A novel method of brachytherapy using local delivery of 99mTc-HMPAO for coronary stent restenosis.
Korean J Intern Med
2004
0.75
43
Indirect Radionuclide Coronary Angiography to Evaluate Gradients of Myocardial Blood Flow and Flow Reserve Through Coronary Stenosis Using N-13 Ammonia PET/CT.
Chonnam Med J
2013
0.75
44
Characteristics of anginal patients with high resting myocardial blood flow measured with N-13 ammonia PET/CT.
Nucl Med Commun
2015
0.75
45
Brain Metastases Mimicking Hyperostosis Frontalis Interna on 99mTc HDP Bone Scintigraphy.
Clin Nucl Med
2016
0.75
46
Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study.
Nucl Med Commun
2017
0.75
47
Pulmonary tuberculosis mimicking pulmonary metastases on ¹³¹I post-therapeutic scan.
Eur J Nucl Med Mol Imaging
2015
0.75
48
Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.
Clin Nucl Med
2016
0.75
49
Indeterminate pleural metastasis on contrast-enhanced chest CT in non-small cell lung cancer: improved differential diagnosis with (18)F-FDG PET/CT.
Ann Nucl Med
2012
0.75
50
Chitosan oligosaccharide inhibits 203HgCl2-induced genotoxicity in mice: micronuclei occurrence and chromosomal aberration.
Arch Pharm Res
2005
0.75
51
Herniation pit mimicking osseous metastasis on 18F-FDG PET/CT in patient with lung cancer.
Clin Nucl Med
2012
0.75
52
Enhanced detectability of recurrent brain tumor using glucose-loading F-18 FDG PET.
Clin Nucl Med
2008
0.75
53
Diffuse soft tissue uptake of I-131 after post-thyroidectomy ablation therapy for thyroid cancer.
Clin Nucl Med
2002
0.75
54
Quantitative Evaluation of incomplete embolization in a patient with portosystemic shunt by per-rectal portal scintigraphy.
Clin Nucl Med
2012
0.75